In adults, T2DM patients with negative islet autoantibodies and preserved C-peptide levels defined by a fasting level > 0.99 ng/mL are likely to retain endogenous β-cell function at 1 year, and they can achieve glycemic control without insulin [6]. This evidence concerns the gene INS and type 2 diabetes mellitus.